Albiglutide

Eperzan

30 MG / 0.5 ML Powder For SolutionCanadaCancelled

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

EperzanBrazil · Glaxosmithkline Brasil LtdaSame brand
EperzanEuropean Union · GlaxoSmithKline Trading Services LimitedSame brand
EPERZAN 30 mg Powder and Solvent For Solution For InjectionSaudi Arabia · Vetter Pharma-Fertigung GMBH & Co. KGSame brand
EPERZAN 50 mg Powder and Solvent For Solution For InjectionSaudi Arabia · Vetter Pharma-Fertigung GMBH & Co. KGSame brand
TanzeumUnited States · 30MG · injectable · Glaxosmithkline LLCSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Albiglutide

Eperzan

30 MG / 0.5 ML Powder For SolutionCanadaCancelled

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tanzeum

United States · 50MG · For Injection · GlaxoSmithKline LLC

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Albiglutide
Strength: 30 MG / 0.5 ML
Dosage form: Powder For Solution
Route: Subcutaneous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Pre Market
Registration: DIN 02443635
Marketing authorisation holder: Glaxosmithkline INC
ATC code: A10BJ04
Group: Alimentary tract and metabolism
Supply: PRESCRIPTION, SCHEDULE D